Aurobindo Pharma has received approval from the USfor the treatment of hypertension

Aurobindo Pharma has received final approval from the US Food and medicines Administration to manufacture and market Ramipril capsules, that are used for the treatment of hypertension.Aurobindo’s Ramipril capsules are the generic equivalent of King Pharmaceuticals’ Altace capsules, and can be launched soon, it said during a notice to stock exchanges.The product had a market size of concerning USD 95 million for twelve months ended September 2010, Aurobindo said citing IMS knowledge.Aurobindo Pharma said it currently has 108 final approvals and 30 tentative approvals from the US FDA.